Patrick Frost, PhD

Patrick Frost, PhD

Jan 13, 2016

Group 6 Copy 42
-1
    Please wait...

    About This Project

    BBRI and Los Angeles VA Medical Center

    Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Why do wolverines need snow?

    A warming climate in the Arctic is having profound impacts on species that rely on snow and ice, like the polar...

    How do we keep wild rhino populations growing during a poaching crisis? The final countdown

    African rhinos are of great economic and ecological importance within their range states,but are threatened...

    Backer Badge Funded